UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease

Current treatment options in gastroenterology, 2024-06, Vol.22 (3), p.134-144

2024

Volltextzugriff (PDF)

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

The American journal of gastroenterology, 2024-06, Vol.119 (6), p.1001-1006

2024

Volltextzugriff (PDF)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.1126-1129

2022

Volltextzugriff (PDF)

Su1556: MATERNAL INFLAMMATORY BOWEL DISEASE DIAGNOSIS BUT NOT GENETIC DETERMINANTS OF THE DISEASE RISK PREDICT FECAL CALPROTECTIN LEVELS DURING EARLY LIFE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-629-S-629

2022

Volltextzugriff (PDF)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-599-S-599

2022

Volltextzugriff (PDF)

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-03, Vol.18 (3), p.145-155

2022

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S104-S105

2022

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S104-S105

2022

Volltextzugriff (PDF)

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1118-1130.e3

2021

Volltextzugriff (PDF)

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1730-1732

Kornbluth, Asher

2020

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Volltextzugriff (PDF)

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

Journal of Crohn's & colitis, 2020-10, Vol.14 (Supplement_3), p.S769-S773

2020

Volltextzugriff (PDF)

164 - Vedolizumab Therapy Induces a Redistribution of CD4+ T Cells to Uninvolved Intestinal Mucosa in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-46-S-46

2018

Volltextzugriff (PDF)

Mo1832 - Baseline Level of Integrin A4B7 on Circulating Plasmablasts Predicts Response to Vedolizumab in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-818-S-818

2018

Volltextzugriff (PDF)

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1719-1721

2017

Volltextzugriff (PDF)

Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S193

2017

Volltextzugriff (PDF)

1062 - Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S193

2017

Volltextzugriff (PDF)

Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances

Treatment of Inflammatory Bowel Disease with Biologics, 2017, p.261-282

2017

Volltextzugriff (PDF)

The First Endoscopy in Suspected Inflammatory Bowel Disease

Gastrointestinal endoscopy clinics of North America, 2016-10, Vol.26 (4), p.593-610

2016

Volltextzugriff (PDF)

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2513-2526

2016

Volltextzugriff (PDF)

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel

Inflammatory bowel diseases, 2016-06, Vol.22 (6), p.1418-1424

2016

Volltextzugriff (PDF)

Su1907 Exploring MEChanisms of IBD traNsmission In Utero through the Microbiome: The MECONIUM Study Pilot

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S585-S585

2016

Volltextzugriff (PDF)

Positioning Therapy for Ulcerative Colitis

Current gastroenterology reports, 2015-08, Vol.17 (8), p.29-29, Article 29

2015

Volltextzugriff (PDF)

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Expert review of gastroenterology & hepatology, 2015-04, Vol.9 (4), p.497-505

2015

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(137)
Buchkapitel
(2)

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Gastroenterology & Hepatology
(58)
Female
(32)
Male
(30)
Adult
(29)
Gastroenterology
(24)
Gastroenterology And Hepatology
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Inflammatory Bowel Disease
(20)
Middle Aged
(20)
Crohn's Disease
(19)
Ulcerative Colitis
(18)
Gastroenterology. Liver. Pancreas. Abdomen
(16)
Other Diseases. Semiology
(16)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(16)
Treatment Outcome
(16)
Crohn Disease - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Su1556: MATERNAL INFLAMMATORY BOWEL DISEASE DIAGNOSIS BUT NOT GENETIC DETERMINANTS OF THE DISEASE RISK PREDICT FECAL CALPROTECTIN LEVELS DURING EARLY LIFE

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

164 - Vedolizumab Therapy Induces a Redistribution of CD4+ T Cells to Uninvolved Intestinal Mucosa in Patients with Inflammatory Bowel Disease

Mo1832 - Baseline Level of Integrin A4B7 on Circulating Plasmablasts Predicts Response to Vedolizumab in Patients with Inflammatory Bowel Disease

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

1062 - Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances

The First Endoscopy in Suspected Inflammatory Bowel Disease

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel

Su1907 Exploring MEChanisms of IBD traNsmission In Utero through the Microbiome: The MECONIUM Study Pilot

Positioning Therapy for Ulcerative Colitis

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Suchergebnisse filtern